Article
A genetic variant in the flanking region of miR-182 could decrease the susceptibility to the breast cancer risk in the iranian population.
Nucleosides, nucleotides & nucleic acids - 1 Jan 2020
Mansouri Maryam, Peymani Maryam, Mohamadynejad Parisa
Abstract excerpt
Breast cancer is one of the most malignant tumors in the world. It is, in fact, the second leading cause of cancer death in women. Recent research has identified the role of miR-182 in this disease as an oncogene agent. In this study, the association of rs4541843 in the flanking region of the miR-182 sequence with the susceptibility to breast cancer risk has been studied in the Iranian population. By using the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
